Search Results 1131-1140 of 11397 for anti-TNF drugs

  1. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well combination chemotherapy and pralatrexate works in treating patients with non-Hodgkin lymphoma (NHL).

  2. Fluocinolone, hydroquinone, and tretinoin (topical application route) - Side effects & dosage - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  3. Evaluating The Addition Of The Immunotherapy Drug Atezolizumab To Standard Chemotherapy Treatment For Advanced Or Metastatic Neuroendocrine Carcinomas That Originate Outside The Lung - Mayo Clinic

    The purpose of this study is to compare the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin ...

  4. A Study Of Macitentan In Pulmonary Hypertension After Left Ventricular Assist Device Implantation - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Treatment with another investigational drug within 28 days prior to study ...

  5. Non-Muscle Invasive Bladder Cancer Clinical Trials - Mayo Clinic Research

    ... treatment. Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Lintuzumab-Ac225 In Older Acute Myeloid Leukemia (AML) Patients - Mayo Clinic

    Participation eligibility · Patients with acute promyelocytic leukemia · Treatment with chemotherapy or biologic therapy within 3 weeks, except for hydroxyurea, ...

  8. Hematology - Clinical trials

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  9. Pneumococcal 13-valent vaccine, diphtheria conjugate (intramuscular route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  10. ACP-196 In Combination With Pembrolizumab, For Treatment Of Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...